阿普洛尔和4-羟基阿普洛尔在人体中的药代动力学与药效学联合研究。 - Suppr

Suppr

超能文献

Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.

作者信息

Ablad B, Borg K O, Johnsson G, Regårdh C G, Sölvell L

出版信息

Life Sci. 1974 Feb 16;14(4):693-704. doi: 10.1016/0024-3205(74)90452-4.

DOI:10.1016/0024-3205(74)90452-4

PMID:4823626

Abstract

摘要

相似文献

Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.

Life Sci. 1974 Feb 16;14(4):693-704. doi: 10.1016/0024-3205(74)90452-4.

Influence of pentobarbital on effect and plasma levels of alprenolol and 4-hydroxy-alprenolol.

Clin Pharmacol Ther. 1979 Apr;25(4):423-7. doi: 10.1002/cpt1979254423.

Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol.

Clin Pharmacol Ther. 1979 Apr;25(4):416-22. doi: 10.1002/cpt1979254416.

Central haemodynamic effects in man of intravenous d-alprenolol during rest and exercise.

Eur J Clin Pharmacol. 1971 Sep;3(4):198-203. doi: 10.1007/BF00565006.

Duration of action of beta-blocking drugs.

Br Med J. 1973 Apr 21;2(5859):177. doi: 10.1136/bmj.2.5859.177-a.

Lack of biological interaction of alprenolol and salicylate in man.

Eur J Clin Pharmacol. 1973 Jun;6(1):9-14. doi: 10.1007/BF00561794.

Absorption, distribution and excretion of alprenolol in man, dog and rat.

Acta Pharmacol Toxicol (Copenh). 1974 Oct;35(4):261-9. doi: 10.1111/j.1600-0773.1974.tb00745.x.

Steady-state plasma concentrations of alprenolol in man.

Eur J Clin Pharmacol. 1974 Aug 23;7(5):353-6. doi: 10.1007/BF00558205.

Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.

Acta Pharmacol Toxicol (Copenh). 1975;37(1):1-39. doi: 10.1111/j.1600-0773.1975.tb03091.x.

Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Eur J Clin Pharmacol. 1976 Jun 15;10(2):85-8. doi: 10.1007/BF00609464.

引用本文的文献

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.

Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

Mol Pharm. 2017 Sep 5;14(9):3069-3086. doi: 10.1021/acs.molpharmaceut.7b00286. Epub 2017 Jul 31.

Soft Drugs VI. The Application of the Inactive Metabolite Approach for Design of Soft β-Blockers1?2.

Pharm Res. 1984 May;1(3):120-5. doi: 10.1023/A:1016376003515.

Bioavailability of beta-adrenoceptor blocking drugs.

Br J Clin Pharmacol. 1976 Dec;3(6):1064-5; author reply 1066. doi: 10.1111/j.1365-2125.1976.tb00361.x.

Individual variation in first-pass metabolism.

Clin Pharmacokinet. 1993 Oct;25(4):300-28. doi: 10.2165/00003088-199325040-00005.

The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.

Clin Pharmacokinet. 1980 Mar-Apr;5(2):181-91. doi: 10.2165/00003088-198005020-00005.

A standard approach to compiling clinical pharmacokinetic data.

J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.

First-pass elimination. Basic concepts and clinical consequences.

Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001.

Steady-state plasma concentrations of alprenolol in man.

Eur J Clin Pharmacol. 1974 Aug 23;7(5):353-6. doi: 10.1007/BF00558205.

Bioavailability assessment and pharmacologic response: impact of first-pass loss when both drug and metabolites are active.

J Pharmacokinet Biopharm. 1988 Dec;16(6):573-93. doi: 10.1007/BF01062013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验